- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Aug 2, 2024 | 77.33M sh |
| Shares Diluted | Q1 2025 · Jun 30, 2024 | 77.16M sh |
| Shares Diluted | Q1 2025 · Jun 30, 2023 | 66.35M sh |
| Operating Cash Flow | Q1 2025 · Jun 30, 2024 | −$104.53M |
| Operating Cash Flow | Q1 2025 · Jun 30, 2023 | −$63.72M |
| Cash And Equivalents | Q1 2025 · Jun 30, 2024 | $152.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $392.51M |
| Stockholders Equity | Q1 2025 · Jun 30, 2024 | −$119.56M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$104.41M |
| Stockholders Equity | Q1 2025 · Jun 30, 2023 | −$751.86M |
| Stockholders Equity | Q1 2025 · Mar 31, 2023 | −$797.4M |
| Current Liabilities | Q1 2025 · Jun 30, 2024 | $303.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $356.26M |
| Current Assets | Q1 2025 · Jun 30, 2024 | $749.76M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $939.37M |
| Total Assets | Q1 2025 · Jun 30, 2024 | $1.49B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $1.69B |
| Eps Diluted | Q1 2025 · Jun 30, 2024 | −$0.18 |
| Eps Diluted | Q1 2025 · Jun 30, 2023 | −$0.27 |
| Eps Basic | Q1 2025 · Jun 30, 2024 | −$0.18 |
| Eps Basic | Q1 2025 · Jun 30, 2023 | −$0.27 |
| Sga Expense | Q1 2025 · Jun 30, 2024 | $49.38M |
| Sga Expense restated | Q1 2025 · Jun 30, 2023 | $50.49M |
| Net Income | Q1 2025 · Jun 30, 2024 | −$14.09M |
| Net Income | Q1 2025 · Jun 30, 2023 | −$18.16M |
| Operating Income | Q1 2025 · Jun 30, 2024 | $8.11M |
| Operating Income restated | Q1 2025 · Jun 30, 2023 | −$558K |
| Cost Of Revenue | Q1 2025 · Jun 30, 2024 | $207.08M |
| Cost Of Revenue restated | Q1 2025 · Jun 30, 2023 | $193.91M |